Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2023
Operating activities
Net increase (decrease) in net assets resulting from operations	$ (1,963,977)	$ 19,993,226
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	0	(74,852)
Change in net unrealized (appreciation) depreciation of investments	3,221,924	(5,216,047)
Net amortization of investment discounts and premiums	(183,446)	(1,990,118)
Interest and dividend income paid in kind	(26,528)	(451,155)
Amortization of deferred debt issuance costs	61,527	142,369
Changes in assets and liabilities:
Purchase of investments	(173,645,582)	(159,904,776)
Proceeds from disposition of investments	2,491,787	45,320,640
Decrease (increase) in interest, dividends and fees receivable	(839,483)	(998,923)
Decrease (increase) in receivable for investments sold	0	(45,566)
Decrease (increase) in prepaid expenses and other assets	(78,089)	(154,467)
Increase (decrease) in payable for investments purchased	6,007,080	(6,792,283)
Increase (decrease) in interest and debt related payables	804,158	611,978
Increase (decrease) in reimbursements due to the Investment Adviser	26,939	114,647
Increase (decrease) in accrued expenses and other liabilities	733,188	1,086,329
Net cash provided by (used in) operating activities	(163,390,502)	(108,358,998)
Financing activities
Proceeds from common shares sold	72,000,000	53,403,818
Contribution received in advance	500,000	10,609,204
Draws on credit facilities	105,000,000	93,000,000
Repayments of credit facility draws	0	(46,000,000)
Payments of debt issuance costs	(1,888,726)	(19,253)
Dividends paid in cash to shareholders	0	(845,839)
Net cash provided by (used in) financing activities	175,611,274	110,147,930
Net increase (decrease) in cash and cash equivalents (including restricted cash)	12,220,772	1,788,932
Cash and cash equivalents (including restricted cash) at beginning of period	0	17,633,729
Cash and cash equivalents (including restricted cash) at end of period	12,220,772	19,422,661
Supplemental cash flow information
Interest payments	0	4,775,918
Excise tax payments	0	18,395
Distribution payable	0	1,715,730
Reinvestment of dividends during the period	$ 0	$ 10,721,128